Edwin George (Wayne State University, MI) discusses the limitations of current therapeutic options for multiple system atrophy (MSA), and what have been the most promising recent advances toward management of the condition.
1. What are the limitations of current therapeutic options in MSA? (0:11)
2. What have been the most promising recent advances in the treatment of MSA? (3:15)
Speaker disclosure: Edwin George is a pro bono advisor on Defeat MSA's scientific and medical board. He also delivers disease awareness talks for Lundbeck Pharmaceuticals.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.